49 related articles for article (PubMed ID: 9309140)
1. [HS1 and EMS1].
He H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1448-53. PubMed ID: 9309140
[TBL] [Abstract][Full Text] [Related]
2. Cortactin regulates cell migration through activation of N-WASP.
Kowalski JR; Egile C; Gil S; Snapper SB; Li R; Thomas SM
J Cell Sci; 2005 Jan; 118(Pt 1):79-87. PubMed ID: 15585574
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation.
He H; Watanabe T; Zhan X; Huang C; Schuuring E; Fukami K; Takenawa T; Kumar CC; Simpson RJ; Maruta H
Mol Cell Biol; 1998 Jul; 18(7):3829-37. PubMed ID: 9632767
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the EMS1 gene and its product, human Cortactin.
Schuuring E; van Damme H; Schuuring-Scholtes E; Verhoeven E; Michalides R; Geelen E; de Boer C; Brok H; van Buuren V; Kluin P
Cell Adhes Commun; 1998; 6(2-3):185-209. PubMed ID: 9823470
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein.
Lin J; Liu J; Wang Y; Zhu J; Zhou K; Smith N; Zhan X
Oncogene; 2005 Mar; 24(12):2059-66. PubMed ID: 15688017
[TBL] [Abstract][Full Text] [Related]
6. Caspase-mediated cleavage of actin-binding and SH3-domain-containing proteins cortactin, HS1, and HIP-55 during apoptosis.
Chen YR; Kori R; John B; Tan TH
Biochem Biophys Res Commun; 2001 Nov; 288(4):981-9. PubMed ID: 11689006
[TBL] [Abstract][Full Text] [Related]
7. Activation of Arp2/3 complex-mediated actin polymerization by cortactin.
Uruno T; Liu J; Zhang P; Fan Yx ; Egile C; Li R; Mueller SC; Zhan X
Nat Cell Biol; 2001 Mar; 3(3):259-66. PubMed ID: 11231575
[TBL] [Abstract][Full Text] [Related]
8. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
[TBL] [Abstract][Full Text] [Related]
9. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
10. Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.
van Rossum AG; Schuuring-Scholtes E; van Buuren-van Seggelen V; Kluin PM; Schuuring E
BMC Genomics; 2005 Feb; 6():15. PubMed ID: 15710041
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.
Patel AS; Schechter GL; Wasilenko WJ; Somers KD
Oncogene; 1998 Jun; 16(25):3227-32. PubMed ID: 9681820
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of protein 4.1R and actin-binding sites in erythrocyte beta spectrin: regulation of the interactions by phosphatidylinositol-4,5-bisphosphate.
An X; Debnath G; Guo X; Liu S; Lux SE; Baines A; Gratzer W; Mohandas N
Biochemistry; 2005 Aug; 44(31):10681-8. PubMed ID: 16060676
[TBL] [Abstract][Full Text] [Related]
14. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
[TBL] [Abstract][Full Text] [Related]
15. NMR structure of an F-actin-binding "headpiece" motif from villin.
Vardar D; Buckley DA; Frank BS; McKnight CJ
J Mol Biol; 1999 Dec; 294(5):1299-310. PubMed ID: 10600386
[TBL] [Abstract][Full Text] [Related]
16. Insights into a single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking.
Hoeflich KP; Tsukita S; Hicks L; Kay CM; Tsukita S; Ikura M
Biochemistry; 2003 Oct; 42(40):11634-41. PubMed ID: 14529273
[TBL] [Abstract][Full Text] [Related]
17. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
18. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
19. Cortactin regulates podosome formation: roles of the protein interaction domains.
Webb BA; Eves R; Mak AS
Exp Cell Res; 2006 Apr; 312(6):760-9. PubMed ID: 16434035
[TBL] [Abstract][Full Text] [Related]
20. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
